Device Trial Radar · NCT01058629
Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses
Last checked: Nov 20, 2026Latest source record: Aug 25, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
125
Planned (sponsor's estimate)
Start
Aug 2009
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- SynergEyes, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 28, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.
Conditions
- Refractive Errors
- Astigmatism
Interventions
SynergEyes A2 Hybrid Contact LensDevice
SynergEyes A2 is a hybrid contact lens cleared by the US Food and Drug Administration (FDA) for daily wear correction of up to +20.00 and -20.00 in eyes with astigmatism up to 6.00D and for presbyopia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parametersTime frame: 6 months
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Family Eye Care Center
Campbell, California
SynergEyes, Inc.
Carlsbad, California
Encino Optometric Center Corp.
Encino, California
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.